Fine-needle aspiration biopsy of metastatic Ewing's sarcoma with MIC2 (CD99) immunocytochemistry

Brian T. Collins, Harvey Cramer, Barbara E. McGahey Frain, Mary M. Davis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The use of fine-needle aspiration biopsy (FNAB) has been infrequently described as a diagnostic modality for Ewing's sarcoma (ES) patient follow- up and management. The purpose of this study is to examine the use and accuracy of FNAB combined with MIC2 immunocytochemistry for evaluating metastases in patients with ES. Records from Saint Louis University Health Sciences Center and Indiana University Medical centers identified patients with known ES who had undergone FNAB for evaluation of potential metastases. Immunocytochemical analysis for MIC2 (CD99) was performed retrospectively on cell blocks and direct aspirate smears. FNABs from nine patients were procured either percutaneously or under radiologic guidance and in all cases a definitive cytologic diagnosis of metastatic ES was rendered. Aspirates were cellular with many single discohesive small round cells and occasional loosely cohesive clusters. The nuclei were round with a fine chromatin pattern and small nucleoli. The cytoplasm was scanty and the nuclear- cytoplasmic ratio was high. Six of six cases showed strongly positive immunocytochemical labeling for MIC2. Immunocytochemistry with MIC2 in FNAB aspirate smears can provide supportive evidence of ES in patients with known disease.

Original languageEnglish
Pages (from-to)382-384
Number of pages3
JournalDiagnostic Cytopathology
Volume19
Issue number5
DOIs
StatePublished - Nov 1998

Fingerprint

Ewing's Sarcoma
Fine Needle Biopsy
Immunohistochemistry
Neoplasm Metastasis
Chromatin
Cytoplasm
Health

Keywords

  • Cytology
  • Ewing's sarcoma
  • Metastases
  • Needle aspirate

ASJC Scopus subject areas

  • Anatomy

Cite this

Fine-needle aspiration biopsy of metastatic Ewing's sarcoma with MIC2 (CD99) immunocytochemistry. / Collins, Brian T.; Cramer, Harvey; McGahey Frain, Barbara E.; Davis, Mary M.

In: Diagnostic Cytopathology, Vol. 19, No. 5, 11.1998, p. 382-384.

Research output: Contribution to journalArticle

Collins, Brian T. ; Cramer, Harvey ; McGahey Frain, Barbara E. ; Davis, Mary M. / Fine-needle aspiration biopsy of metastatic Ewing's sarcoma with MIC2 (CD99) immunocytochemistry. In: Diagnostic Cytopathology. 1998 ; Vol. 19, No. 5. pp. 382-384.
@article{0910dd65cb894a4683474a8d21abd029,
title = "Fine-needle aspiration biopsy of metastatic Ewing's sarcoma with MIC2 (CD99) immunocytochemistry",
abstract = "The use of fine-needle aspiration biopsy (FNAB) has been infrequently described as a diagnostic modality for Ewing's sarcoma (ES) patient follow- up and management. The purpose of this study is to examine the use and accuracy of FNAB combined with MIC2 immunocytochemistry for evaluating metastases in patients with ES. Records from Saint Louis University Health Sciences Center and Indiana University Medical centers identified patients with known ES who had undergone FNAB for evaluation of potential metastases. Immunocytochemical analysis for MIC2 (CD99) was performed retrospectively on cell blocks and direct aspirate smears. FNABs from nine patients were procured either percutaneously or under radiologic guidance and in all cases a definitive cytologic diagnosis of metastatic ES was rendered. Aspirates were cellular with many single discohesive small round cells and occasional loosely cohesive clusters. The nuclei were round with a fine chromatin pattern and small nucleoli. The cytoplasm was scanty and the nuclear- cytoplasmic ratio was high. Six of six cases showed strongly positive immunocytochemical labeling for MIC2. Immunocytochemistry with MIC2 in FNAB aspirate smears can provide supportive evidence of ES in patients with known disease.",
keywords = "Cytology, Ewing's sarcoma, Metastases, Needle aspirate",
author = "Collins, {Brian T.} and Harvey Cramer and {McGahey Frain}, {Barbara E.} and Davis, {Mary M.}",
year = "1998",
month = "11",
doi = "10.1002/(SICI)1097-0339(199811)19:5<382::AID-DC15>3.0.CO;2-Q",
language = "English",
volume = "19",
pages = "382--384",
journal = "Diagnostic Cytopathology",
issn = "8755-1039",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Fine-needle aspiration biopsy of metastatic Ewing's sarcoma with MIC2 (CD99) immunocytochemistry

AU - Collins, Brian T.

AU - Cramer, Harvey

AU - McGahey Frain, Barbara E.

AU - Davis, Mary M.

PY - 1998/11

Y1 - 1998/11

N2 - The use of fine-needle aspiration biopsy (FNAB) has been infrequently described as a diagnostic modality for Ewing's sarcoma (ES) patient follow- up and management. The purpose of this study is to examine the use and accuracy of FNAB combined with MIC2 immunocytochemistry for evaluating metastases in patients with ES. Records from Saint Louis University Health Sciences Center and Indiana University Medical centers identified patients with known ES who had undergone FNAB for evaluation of potential metastases. Immunocytochemical analysis for MIC2 (CD99) was performed retrospectively on cell blocks and direct aspirate smears. FNABs from nine patients were procured either percutaneously or under radiologic guidance and in all cases a definitive cytologic diagnosis of metastatic ES was rendered. Aspirates were cellular with many single discohesive small round cells and occasional loosely cohesive clusters. The nuclei were round with a fine chromatin pattern and small nucleoli. The cytoplasm was scanty and the nuclear- cytoplasmic ratio was high. Six of six cases showed strongly positive immunocytochemical labeling for MIC2. Immunocytochemistry with MIC2 in FNAB aspirate smears can provide supportive evidence of ES in patients with known disease.

AB - The use of fine-needle aspiration biopsy (FNAB) has been infrequently described as a diagnostic modality for Ewing's sarcoma (ES) patient follow- up and management. The purpose of this study is to examine the use and accuracy of FNAB combined with MIC2 immunocytochemistry for evaluating metastases in patients with ES. Records from Saint Louis University Health Sciences Center and Indiana University Medical centers identified patients with known ES who had undergone FNAB for evaluation of potential metastases. Immunocytochemical analysis for MIC2 (CD99) was performed retrospectively on cell blocks and direct aspirate smears. FNABs from nine patients were procured either percutaneously or under radiologic guidance and in all cases a definitive cytologic diagnosis of metastatic ES was rendered. Aspirates were cellular with many single discohesive small round cells and occasional loosely cohesive clusters. The nuclei were round with a fine chromatin pattern and small nucleoli. The cytoplasm was scanty and the nuclear- cytoplasmic ratio was high. Six of six cases showed strongly positive immunocytochemical labeling for MIC2. Immunocytochemistry with MIC2 in FNAB aspirate smears can provide supportive evidence of ES in patients with known disease.

KW - Cytology

KW - Ewing's sarcoma

KW - Metastases

KW - Needle aspirate

UR - http://www.scopus.com/inward/record.url?scp=0031764073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031764073&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0339(199811)19:5<382::AID-DC15>3.0.CO;2-Q

DO - 10.1002/(SICI)1097-0339(199811)19:5<382::AID-DC15>3.0.CO;2-Q

M3 - Article

VL - 19

SP - 382

EP - 384

JO - Diagnostic Cytopathology

JF - Diagnostic Cytopathology

SN - 8755-1039

IS - 5

ER -